CK effective over the long-term

Article

Conductive keratoplasty (CK) is an effective long-term treatment for near-plano presbyopia.

Conductive keratoplasty (CK) is an effective long-term treatment for near-plano presbyopia, according to the results of a study published in the November issue of the Journal of Refractive Surgery.

Jason Stahl, MD from Kansas University Medical Center, Kansas, US evaluated the outcomes of 10 patients treated with unilateral CK, performed using the ViewPoint CK system (Refractec). Nine patients were available for follow-up at three years.

Preoperatively, the average manifest refraction spherical equivalent (MRSE) was -0.17 D and average near uncorrected visual acuity (UCVA) was J10. At three years follow-up, the mean MRSE had decreased to -1.06 D, representing a 0.25 D change from the average MRSE of -1.31 D at one year follow-up. Furthermore, at three years, all subjects had maintained an uncorrected binocular distance visual acuity of 20/20 and near UCVA averaged J3 or better in 78% of subjects.

Dr Stahl concluded that CK can be an effective long-term treatment for presbyopia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.